by Vora Corporate Finance | Dec 2, 2023 | Insights
Secondary Market Update: Markets corrected on account of growing fears of global inflation and an economic downturn, concerns about the lackluster corporate earnings of Indian companies and rising geopolitical tensions in the Middle East. Nifty 50 lost 2.84% and...
by Vora Corporate Finance | Dec 2, 2023 | Insights
Economic Update: India, the world’s fifth largest economy in the world, is likely to overtake Japan to become the world’s third-largest economy with a GDP of $7.3 trillion by 2030 as per projections by S&P Global Market Intelligence. The acceleration...
by Vora Corporate Finance | Nov 4, 2023 | Articles, Capital Market Updates
The Indian GDP growth came in at a solid 7.8% YoY in Q1 FY 2024 with both consumption and investment activity growing at robust rate. World leaders will be in India for the G20 meet. Nifty 50 and Sensex correctedmarginally August 2023, however midcap index was able to...
by Vora Corporate Finance | Oct 28, 2023 | Insights, Private Equity & IPO
Transaction: India Resurgence Fund (IndiaRF), promoted by Piramal Enterprises Limited and Bain Capital, Invested Rs. 525 Crores in Ivy Health and Life Sciences Private Limited (Ivy). The hospital is estimated to be valued at Rs 1100 Crores. About India Resurgence Fund...
by Vora Corporate Finance | Oct 28, 2023 | Insights, Merger & Acquisitions
Transaction: Glenmark Pharmaceuticals Limited (GPL) has entered into a share purchase agreement with Nirma Limited to divest a 75% stake in Glenmark Lifesciences (GLS) at an EV of Rs 7500 Crores. Current Promoter group to be public shareholders. About Glenmark...
